GSE26712: A gene signature predicting for survival in suboptimally...
In mzon7/MetaGxOvarian: Transcriptomic Ovarian Cancer Datasets
Description
Format
Details
Value
Description
Despite the existence of morphologically indistinguishable disease, patients with advanced ovarian tumors display a broad range of survival end points. We hypothesize that gene expression profiling can identify a prognostic signature accounting for these distinct clinical outcomes. To resolve survival-associated loci, gene expression profiling was completed for an extensive set of 185 (90 optimal/95 suboptimal) primary ovarian tumors using the Affymetrix human U133A microarray. Cox regression analysis identified probe sets associated with survival in optimally and suboptimally debulked tumor sets at a P value of <0.01. Leave-one-out cross-validation was applied to each tumor cohort and confirmed by a permutation test. External validation was conducted by applying the gene signature to a publicly available array database of expression profiles of advanced stage suboptimally debulked tumors. The prognostic signature successfully classified the tumors according to survival for suboptimally (P = 0.0179) but not optimally debulked (P = 0.144) patients. The suboptimal gene signature was validated using the independent set of tumors (odds ratio, 8.75; P = 0.0146). To elucidate signaling events amenable to therapeutic intervention in suboptimally debulked patients, pathway analysis was completed for the top 57 survival-associated probe sets. For suboptimally debulked patients, confirmation of the predictive gene signature supports the existence of a clinically relevant predictor, as well as the possibility of novel therapeutic opportunities. Ultimately, the prognostic classifier defined for suboptimally debulked tumors may aid in the classification and enhancement of patient outcome for this high-risk population.
Format
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
experimentData(eset):
Experiment data
Experimenter name: Bonome T, Levine DA, Shih J, Randonovich M, Pise-Masison CA, Bogomolniy F, Ozbun L, Brady J, Barrett JC, Boyd J, Birrer MJ: A Gene Signature Predicting for Survival in Suboptimally Debulked Patients with Ovarian Cancer. Cancer Research 2008, 68:5478 -5486.
Laboratory: Bonome, Birrer 2008
Contact information:
Title: A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer.
URL:
PMIDs: 18593951
Abstract: A 238 word abstract is available. Use 'abstract' method.
Information is available on: preprocessing
notes:
platform_title:
[HG-U133A] Affymetrix Human Genome U133A Array
platform_shorttitle:
Affymetrix HG-U133A
platform_summary:
hgu133a
platform_manufacturer:
Affymetrix
platform_distribution:
commercial
platform_accession:
GPL96
version:
2015-09-22 19:46:24
featureData(eset):
An object of class 'AnnotatedDataFrame'
featureNames: 1007_s_at 1053_at ... AFFX-HUMISGF3A/M97935_MB_at
(20967 total)
varLabels: probeset gene EntrezGene.ID best_probe
varMetadata: labelDescription
Details
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
assayData: 20967 features, 195 samples
Platform type:
Overall survival time-to-event summary (in years):
Call: survfit(formula = Surv(time, cens) ~ -1)
10 observations deleted due to missingness
n events median 0.95LCL 0.95UCL
185.00 129.00 3.83 3.24 4.83
---------------------------
Available sample meta-data:
---------------------------
alt_sample_name:
Normal HOSE2008 Normal HOSE2061 Normal HOSE2064
1 1 1
Normal HOSE2085 Normal HOSE2225 Normal HOSE2226
1 1 1
Normal HOSE2228 Normal HOSE2230 Normal HOSE2234
1 1 1
Normal HOSE2237 Ovarian Cancer SO10 Ovarian Cancer SO100
1 1 1
Ovarian Cancer SO103 Ovarian Cancer SO106 Ovarian Cancer SO108
1 1 1
Ovarian Cancer SO11 Ovarian Cancer SO113 Ovarian Cancer SO115
1 1 1
Ovarian Cancer SO116 Ovarian Cancer SO117 Ovarian Cancer SO118
1 1 1
Ovarian Cancer SO12 Ovarian Cancer SO121 Ovarian Cancer SO122
1 1 1
Ovarian Cancer SO124 Ovarian Cancer SO129 Ovarian Cancer SO13
1 1 1
Ovarian Cancer SO131 Ovarian Cancer SO134 Ovarian Cancer SO135
1 1 1
Ovarian Cancer SO137 Ovarian Cancer SO141 Ovarian Cancer SO143
1 1 1
Ovarian Cancer SO148 Ovarian Cancer SO154 Ovarian Cancer SO16
1 1 1
Ovarian Cancer SO166 Ovarian Cancer SO17 Ovarian Cancer SO173
1 1 1
Ovarian Cancer SO174 Ovarian Cancer SO18 Ovarian Cancer SO181
1 1 1
Ovarian Cancer SO184 Ovarian Cancer SO185 Ovarian Cancer SO187
1 1 1
Ovarian Cancer SO189 Ovarian Cancer SO190 Ovarian Cancer SO193
1 1 1
Ovarian Cancer SO194 Ovarian Cancer SO196 Ovarian Cancer SO197
1 1 1
Ovarian Cancer SO2 Ovarian Cancer SO200 Ovarian Cancer SO201
1 1 1
Ovarian Cancer SO203 Ovarian Cancer SO205 Ovarian Cancer SO21
1 1 1
Ovarian Cancer SO211 Ovarian Cancer SO214 Ovarian Cancer SO216
1 1 1
Ovarian Cancer SO217 Ovarian Cancer SO218 Ovarian Cancer SO224
1 1 1
Ovarian Cancer SO225 Ovarian Cancer SO227 Ovarian Cancer SO228
1 1 1
Ovarian Cancer SO229 Ovarian Cancer SO23 Ovarian Cancer SO230
1 1 1
Ovarian Cancer SO231 Ovarian Cancer SO235 Ovarian Cancer SO236
1 1 1
Ovarian Cancer SO237 Ovarian Cancer SO241 Ovarian Cancer SO242
1 1 1
Ovarian Cancer SO243 Ovarian Cancer SO244 Ovarian Cancer SO246
1 1 1
Ovarian Cancer SO247 Ovarian Cancer SO249 Ovarian Cancer SO25
1 1 1
Ovarian Cancer SO250 Ovarian Cancer SO256 Ovarian Cancer SO257
1 1 1
Ovarian Cancer SO258 Ovarian Cancer SO261 Ovarian Cancer SO262
1 1 1
Ovarian Cancer SO263 Ovarian Cancer SO265 Ovarian Cancer SO267
1 1 1
Ovarian Cancer SO268 Ovarian Cancer SO272 Ovarian Cancer SO273
1 1 1
Ovarian Cancer SO278 Ovarian Cancer SO279 Ovarian Cancer SO282
1 1 1
Ovarian Cancer SO283 Ovarian Cancer SO285 Ovarian Cancer SO290
1 1 1
(Other)
96
sample_type:
healthy tumor
10 185
histological_type:
ser NA's
185 10
primarysite:
ov
195
summarygrade:
high NA's
185 10
summarystage:
late NA's
185 10
tumorstage:
3 4 NA's
146 36 13
substage:
b c NA's
9 137 49
age_at_initial_pathologic_diagnosis:
Min. 1st Qu. Median Mean 3rd Qu. Max. NA's
26.00 52.00 63.00 61.54 70.00 84.00 13
recurrence_status:
norecurrence recurrence
42 153
days_to_death:
Min. 1st Qu. Median Mean 3rd Qu. Max. NA's
21.9 660.6 1164.0 1429.0 1880.0 4982.0 10
vital_status:
deceased living NA's
129 56 10
debulking:
optimal suboptimal NA's
90 95 10
percent_normal_cells:
20-
195
percent_stromal_cells:
20-
195
percent_tumor_cells:
80+
195
batch:
2003-11-04 2003-11-05 2003-11-06 2003-11-07 2003-11-20 2003-11-21 2003-12-16
14 16 9 6 10 15 17
2003-12-23 2003-12-24 2004-04-20 2004-04-21 2004-04-27 2004-09-28 2005-07-27
12 11 20 17 9 14 15
2006-11-09
10
uncurated_author_metadata:
title: Normal HOSE2008///geo_accession: GSM657520///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian surface epithelial cells///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Normal ovarian surface epithelium///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from ovarian surface epithelial cells///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657520/GSM657520_HOSE2008.CEL.gz///data_row_count: 22283
1
title: Normal HOSE2061///geo_accession: GSM657521///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian surface epithelial cells///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Normal ovarian surface epithelium///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from ovarian surface epithelial cells///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657521/GSM657521_HOSE2061.CEL.gz///data_row_count: 22283
1
title: Normal HOSE2064///geo_accession: GSM657522///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian surface epithelial cells///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Normal ovarian surface epithelium///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from ovarian surface epithelial cells///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657522/GSM657522_HOSE2064.CEL.gz///data_row_count: 22283
1
title: Normal HOSE2085///geo_accession: GSM657523///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian surface epithelial cells///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Normal ovarian surface epithelium///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from ovarian surface epithelial cells///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657523/GSM657523_HOSE2085.CEL.gz///data_row_count: 22283
1
title: Normal HOSE2225///geo_accession: GSM657524///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian surface epithelial cells///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Normal ovarian surface epithelium///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from ovarian surface epithelial cells///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657524/GSM657524_HOSE2225.CEL.gz///data_row_count: 22283
1
title: Normal HOSE2226///geo_accession: GSM657525///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian surface epithelial cells///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Normal ovarian surface epithelium///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from ovarian surface epithelial cells///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657525/GSM657525_HOSE2226.CEL.gz///data_row_count: 22283
1
title: Normal HOSE2228///geo_accession: GSM657526///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian surface epithelial cells///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Normal ovarian surface epithelium///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from ovarian surface epithelial cells///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657526/GSM657526_HOSE2228.CEL.gz///data_row_count: 22283
1
title: Normal HOSE2230///geo_accession: GSM657527///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian surface epithelial cells///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Normal ovarian surface epithelium///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from ovarian surface epithelial cells///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657527/GSM657527_HOSE2230.CEL.gz///data_row_count: 22283
1
title: Normal HOSE2234///geo_accession: GSM657528///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian surface epithelial cells///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Normal ovarian surface epithelium///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from ovarian surface epithelial cells///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657528/GSM657528_HOSE2234.CEL.gz///data_row_count: 22283
1
title: Normal HOSE2237///geo_accession: GSM657519///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian surface epithelial cells///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Normal ovarian surface epithelium///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from ovarian surface epithelial cells///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657519/GSM657519_HOSE2237.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO100///geo_accession: GSM657530///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 4.51///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657530/GSM657530_SO100.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO103///geo_accession: GSM657531///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 4.38///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657531/GSM657531_SO103.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO106///geo_accession: GSM657532///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 1.72///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657532/GSM657532_SO106.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO108///geo_accession: GSM657533///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: AWD (alive with disease)///characteristics_ch1.3: survival years: 3.99///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657533/GSM657533_SO108.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO10///geo_accession: GSM657529///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: AWD (alive with disease)///characteristics_ch1.3: survival years: 7.48///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657529/GSM657529_SO10.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO113///geo_accession: GSM657535///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 3.77///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657535/GSM657535_SO113.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO115///geo_accession: GSM657536///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 2.45///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657536/GSM657536_SO115.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO116///geo_accession: GSM657537///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: AWD (alive with disease)///characteristics_ch1.3: survival years: 3.58///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657537/GSM657537_SO116.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO117///geo_accession: GSM657538///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: AWD (alive with disease)///characteristics_ch1.3: survival years: 3.53///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657538/GSM657538_SO117.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO118///geo_accession: GSM657539///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: AWD (alive with disease)///characteristics_ch1.3: survival years: 3.49///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657539/GSM657539_SO118.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO11///geo_accession: GSM657534///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 2.51///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657534/GSM657534_SO11.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO121///geo_accession: GSM657541///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 3.3///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657541/GSM657541_SO121.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO122///geo_accession: GSM657542///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 2.3///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657542/GSM657542_SO122.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO124///geo_accession: GSM657543///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 3.26///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657543/GSM657543_SO124.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO129///geo_accession: GSM657544///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 2.82///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657544/GSM657544_SO129.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO12///geo_accession: GSM657540///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 0.71///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657540/GSM657540_SO12.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO131///geo_accession: GSM657546///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 2.94///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657546/GSM657546_SO131.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO134///geo_accession: GSM657547///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 1.03///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657547/GSM657547_SO134.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO135///geo_accession: GSM657548///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 3.55///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657548/GSM657548_SO135.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO137///geo_accession: GSM657549///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 0.17///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657549/GSM657549_SO137.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO13///geo_accession: GSM657545///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 7.33///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657545/GSM657545_SO13.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO141///geo_accession: GSM657550///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 1.47///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657550/GSM657550_SO141.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO143///geo_accession: GSM657551///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: AWD (alive with disease)///characteristics_ch1.3: survival years: 6.86///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657551/GSM657551_SO143.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO148///geo_accession: GSM657552///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 2.37///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657552/GSM657552_SO148.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO154///geo_accession: GSM657553///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: AWD (alive with disease)///characteristics_ch1.3: survival years: 3.7///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657553/GSM657553_SO154.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO166///geo_accession: GSM657555///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 2.93///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657555/GSM657555_SO166.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO16///geo_accession: GSM657554///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 6.29///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657554/GSM657554_SO16.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO173///geo_accession: GSM657557///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: AWD (alive with disease)///characteristics_ch1.3: survival years: 2.71///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657557/GSM657557_SO173.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO174///geo_accession: GSM657558///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 2.84///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657558/GSM657558_SO174.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO17///geo_accession: GSM657556///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 3.83///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657556/GSM657556_SO17.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO181///geo_accession: GSM657560///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 2.1///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657560/GSM657560_SO181.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO184///geo_accession: GSM657561///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 2.43///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657561/GSM657561_SO184.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO185///geo_accession: GSM657562///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 2.37///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657562/GSM657562_SO185.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO187///geo_accession: GSM657563///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: AWD (alive with disease)///characteristics_ch1.3: survival years: 2.48///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657563/GSM657563_SO187.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO189///geo_accession: GSM657564///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 2.3///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657564/GSM657564_SO189.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO18///geo_accession: GSM657559///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 6.3///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657559/GSM657559_SO18.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO190///geo_accession: GSM657565///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 2.16///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657565/GSM657565_SO190.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO193///geo_accession: GSM657566///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: AWD (alive with disease)///characteristics_ch1.3: survival years: 2.27///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657566/GSM657566_SO193.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO194///geo_accession: GSM657567///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: AWD (alive with disease)///characteristics_ch1.3: survival years: 2.23///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657567/GSM657567_SO194.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO196///geo_accession: GSM657568///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 1.28///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657568/GSM657568_SO196.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO197///geo_accession: GSM657569///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: AWD (alive with disease)///characteristics_ch1.3: survival years: 2.16///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657569/GSM657569_SO197.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO200///geo_accession: GSM657571///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: AWD (alive with disease)///characteristics_ch1.3: survival years: 2.15///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657571/GSM657571_SO200.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO201///geo_accession: GSM657572///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: AWD (alive with disease)///characteristics_ch1.3: survival years: 2.06///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657572/GSM657572_SO201.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO203///geo_accession: GSM657573///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 1.59///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657573/GSM657573_SO203.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO205///geo_accession: GSM657574///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 1.89///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657574/GSM657574_SO205.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO211///geo_accession: GSM657576///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 4.94///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657576/GSM657576_SO211.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO214///geo_accession: GSM657577///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 2.96///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657577/GSM657577_SO214.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO216///geo_accession: GSM657578///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 1.75///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657578/GSM657578_SO216.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO217///geo_accession: GSM657579///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 1.91///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657579/GSM657579_SO217.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO218///geo_accession: GSM657580///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 4.6///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657580/GSM657580_SO218.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO21///geo_accession: GSM657575///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 0.56///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657575/GSM657575_SO21.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO224///geo_accession: GSM657581///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 3.18///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657581/GSM657581_SO224.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO225///geo_accession: GSM657582///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 8.8///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657582/GSM657582_SO225.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO227///geo_accession: GSM657583///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 5.68///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657583/GSM657583_SO227.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO228///geo_accession: GSM657584///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 6.75///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657584/GSM657584_SO228.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO229///geo_accession: GSM657585///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 0.86///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657585/GSM657585_SO229.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO230///geo_accession: GSM657587///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 3.64///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657587/GSM657587_SO230.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO231///geo_accession: GSM657588///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 5.15///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657588/GSM657588_SO231.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO235///geo_accession: GSM657589///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 0.62///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657589/GSM657589_SO235.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO236///geo_accession: GSM657590///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 13.5///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657590/GSM657590_SO236.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO237///geo_accession: GSM657591///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 0.59///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657591/GSM657591_SO237.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO23///geo_accession: GSM657586///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 6.91///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657586/GSM657586_SO23.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO241///geo_accession: GSM657592///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 3.12///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657592/GSM657592_SO241.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO242///geo_accession: GSM657593///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 0.21///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657593/GSM657593_SO242.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO243///geo_accession: GSM657594///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 13.1///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657594/GSM657594_SO243.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO244///geo_accession: GSM657595///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 0.99///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657595/GSM657595_SO244.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO246///geo_accession: GSM657596///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 3.95///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657596/GSM657596_SO246.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO247///geo_accession: GSM657597///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 5.34///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657597/GSM657597_SO247.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO249///geo_accession: GSM657598///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 6.83///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657598/GSM657598_SO249.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO250///geo_accession: GSM657600///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 8.64///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657600/GSM657600_SO250.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO256///geo_accession: GSM657601///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 1.94///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657601/GSM657601_SO256.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO257///geo_accession: GSM657602///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 2.2///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657602/GSM657602_SO257.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO258///geo_accession: GSM657603///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 1.72///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657603/GSM657603_SO258.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO25///geo_accession: GSM657599///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 3.5///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657599/GSM657599_SO25.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO261///geo_accession: GSM657604///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 0.98///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657604/GSM657604_SO261.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO262///geo_accession: GSM657605///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 7.88///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657605/GSM657605_SO262.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO263///geo_accession: GSM657606///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 3.93///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657606/GSM657606_SO263.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO265///geo_accession: GSM657607///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 0.33///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657607/GSM657607_SO265.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO267///geo_accession: GSM657608///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 1.3///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657608/GSM657608_SO267.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO268///geo_accession: GSM657609///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 9.22///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657609/GSM657609_SO268.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO272///geo_accession: GSM657610///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 3.75///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657610/GSM657610_SO272.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO273///geo_accession: GSM657611///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 2.52///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657611/GSM657611_SO273.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO278///geo_accession: GSM657612///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 4.53///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657612/GSM657612_SO278.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO279///geo_accession: GSM657613///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 0.92///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657613/GSM657613_SO279.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO282///geo_accession: GSM657614///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 2.4///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657614/GSM657614_SO282.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO283///geo_accession: GSM657615///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 0.66///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657615/GSM657615_SO283.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO285///geo_accession: GSM657616///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 2.32///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657616/GSM657616_SO285.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO290///geo_accession: GSM657617///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 3.5///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657617/GSM657617_SO290.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO295///geo_accession: GSM657618///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 3.24///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657618/GSM657618_SO295.CEL.gz///data_row_count: 22283
1
(Other)
96
duplicates:
GSE26712.GSE26712_GSM657526
1
GSE26712.GSE26712_GSM657526///GSE26712.GSE26712_GSM657527
1
GSE26712.GSE26712_GSM657527
1
NA's
192
Value
An expression set
mzon7/MetaGxOvarian documentation built on May 17, 2019, 10:39 a.m.
R Package Documentation
Browse R Packages
We want your feedback!
Note that we can't provide technical support on individual packages. You should contact the package authors for that.
Description Format Details Value
Description
Despite the existence of morphologically indistinguishable disease, patients with advanced ovarian tumors display a broad range of survival end points. We hypothesize that gene expression profiling can identify a prognostic signature accounting for these distinct clinical outcomes. To resolve survival-associated loci, gene expression profiling was completed for an extensive set of 185 (90 optimal/95 suboptimal) primary ovarian tumors using the Affymetrix human U133A microarray. Cox regression analysis identified probe sets associated with survival in optimally and suboptimally debulked tumor sets at a P value of <0.01. Leave-one-out cross-validation was applied to each tumor cohort and confirmed by a permutation test. External validation was conducted by applying the gene signature to a publicly available array database of expression profiles of advanced stage suboptimally debulked tumors. The prognostic signature successfully classified the tumors according to survival for suboptimally (P = 0.0179) but not optimally debulked (P = 0.144) patients. The suboptimal gene signature was validated using the independent set of tumors (odds ratio, 8.75; P = 0.0146). To elucidate signaling events amenable to therapeutic intervention in suboptimally debulked patients, pathway analysis was completed for the top 57 survival-associated probe sets. For suboptimally debulked patients, confirmation of the predictive gene signature supports the existence of a clinically relevant predictor, as well as the possibility of novel therapeutic opportunities. Ultimately, the prognostic classifier defined for suboptimally debulked tumors may aid in the classification and enhancement of patient outcome for this high-risk population.
Format
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 | experimentData(eset):
Experiment data
Experimenter name: Bonome T, Levine DA, Shih J, Randonovich M, Pise-Masison CA, Bogomolniy F, Ozbun L, Brady J, Barrett JC, Boyd J, Birrer MJ: A Gene Signature Predicting for Survival in Suboptimally Debulked Patients with Ovarian Cancer. Cancer Research 2008, 68:5478 -5486.
Laboratory: Bonome, Birrer 2008
Contact information:
Title: A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer.
URL:
PMIDs: 18593951
Abstract: A 238 word abstract is available. Use 'abstract' method.
Information is available on: preprocessing
notes:
platform_title:
[HG-U133A] Affymetrix Human Genome U133A Array
platform_shorttitle:
Affymetrix HG-U133A
platform_summary:
hgu133a
platform_manufacturer:
Affymetrix
platform_distribution:
commercial
platform_accession:
GPL96
version:
2015-09-22 19:46:24
featureData(eset):
An object of class 'AnnotatedDataFrame'
featureNames: 1007_s_at 1053_at ... AFFX-HUMISGF3A/M97935_MB_at
(20967 total)
varLabels: probeset gene EntrezGene.ID best_probe
varMetadata: labelDescription
|
Details
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 | assayData: 20967 features, 195 samples
Platform type:
Overall survival time-to-event summary (in years):
Call: survfit(formula = Surv(time, cens) ~ -1)
10 observations deleted due to missingness
n events median 0.95LCL 0.95UCL
185.00 129.00 3.83 3.24 4.83
---------------------------
Available sample meta-data:
---------------------------
alt_sample_name:
Normal HOSE2008 Normal HOSE2061 Normal HOSE2064
1 1 1
Normal HOSE2085 Normal HOSE2225 Normal HOSE2226
1 1 1
Normal HOSE2228 Normal HOSE2230 Normal HOSE2234
1 1 1
Normal HOSE2237 Ovarian Cancer SO10 Ovarian Cancer SO100
1 1 1
Ovarian Cancer SO103 Ovarian Cancer SO106 Ovarian Cancer SO108
1 1 1
Ovarian Cancer SO11 Ovarian Cancer SO113 Ovarian Cancer SO115
1 1 1
Ovarian Cancer SO116 Ovarian Cancer SO117 Ovarian Cancer SO118
1 1 1
Ovarian Cancer SO12 Ovarian Cancer SO121 Ovarian Cancer SO122
1 1 1
Ovarian Cancer SO124 Ovarian Cancer SO129 Ovarian Cancer SO13
1 1 1
Ovarian Cancer SO131 Ovarian Cancer SO134 Ovarian Cancer SO135
1 1 1
Ovarian Cancer SO137 Ovarian Cancer SO141 Ovarian Cancer SO143
1 1 1
Ovarian Cancer SO148 Ovarian Cancer SO154 Ovarian Cancer SO16
1 1 1
Ovarian Cancer SO166 Ovarian Cancer SO17 Ovarian Cancer SO173
1 1 1
Ovarian Cancer SO174 Ovarian Cancer SO18 Ovarian Cancer SO181
1 1 1
Ovarian Cancer SO184 Ovarian Cancer SO185 Ovarian Cancer SO187
1 1 1
Ovarian Cancer SO189 Ovarian Cancer SO190 Ovarian Cancer SO193
1 1 1
Ovarian Cancer SO194 Ovarian Cancer SO196 Ovarian Cancer SO197
1 1 1
Ovarian Cancer SO2 Ovarian Cancer SO200 Ovarian Cancer SO201
1 1 1
Ovarian Cancer SO203 Ovarian Cancer SO205 Ovarian Cancer SO21
1 1 1
Ovarian Cancer SO211 Ovarian Cancer SO214 Ovarian Cancer SO216
1 1 1
Ovarian Cancer SO217 Ovarian Cancer SO218 Ovarian Cancer SO224
1 1 1
Ovarian Cancer SO225 Ovarian Cancer SO227 Ovarian Cancer SO228
1 1 1
Ovarian Cancer SO229 Ovarian Cancer SO23 Ovarian Cancer SO230
1 1 1
Ovarian Cancer SO231 Ovarian Cancer SO235 Ovarian Cancer SO236
1 1 1
Ovarian Cancer SO237 Ovarian Cancer SO241 Ovarian Cancer SO242
1 1 1
Ovarian Cancer SO243 Ovarian Cancer SO244 Ovarian Cancer SO246
1 1 1
Ovarian Cancer SO247 Ovarian Cancer SO249 Ovarian Cancer SO25
1 1 1
Ovarian Cancer SO250 Ovarian Cancer SO256 Ovarian Cancer SO257
1 1 1
Ovarian Cancer SO258 Ovarian Cancer SO261 Ovarian Cancer SO262
1 1 1
Ovarian Cancer SO263 Ovarian Cancer SO265 Ovarian Cancer SO267
1 1 1
Ovarian Cancer SO268 Ovarian Cancer SO272 Ovarian Cancer SO273
1 1 1
Ovarian Cancer SO278 Ovarian Cancer SO279 Ovarian Cancer SO282
1 1 1
Ovarian Cancer SO283 Ovarian Cancer SO285 Ovarian Cancer SO290
1 1 1
(Other)
96
sample_type:
healthy tumor
10 185
histological_type:
ser NA's
185 10
primarysite:
ov
195
summarygrade:
high NA's
185 10
summarystage:
late NA's
185 10
tumorstage:
3 4 NA's
146 36 13
substage:
b c NA's
9 137 49
age_at_initial_pathologic_diagnosis:
Min. 1st Qu. Median Mean 3rd Qu. Max. NA's
26.00 52.00 63.00 61.54 70.00 84.00 13
recurrence_status:
norecurrence recurrence
42 153
days_to_death:
Min. 1st Qu. Median Mean 3rd Qu. Max. NA's
21.9 660.6 1164.0 1429.0 1880.0 4982.0 10
vital_status:
deceased living NA's
129 56 10
debulking:
optimal suboptimal NA's
90 95 10
percent_normal_cells:
20-
195
percent_stromal_cells:
20-
195
percent_tumor_cells:
80+
195
batch:
2003-11-04 2003-11-05 2003-11-06 2003-11-07 2003-11-20 2003-11-21 2003-12-16
14 16 9 6 10 15 17
2003-12-23 2003-12-24 2004-04-20 2004-04-21 2004-04-27 2004-09-28 2005-07-27
12 11 20 17 9 14 15
2006-11-09
10
uncurated_author_metadata:
title: Normal HOSE2008///geo_accession: GSM657520///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian surface epithelial cells///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Normal ovarian surface epithelium///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from ovarian surface epithelial cells///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657520/GSM657520_HOSE2008.CEL.gz///data_row_count: 22283
1
title: Normal HOSE2061///geo_accession: GSM657521///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian surface epithelial cells///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Normal ovarian surface epithelium///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from ovarian surface epithelial cells///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657521/GSM657521_HOSE2061.CEL.gz///data_row_count: 22283
1
title: Normal HOSE2064///geo_accession: GSM657522///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian surface epithelial cells///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Normal ovarian surface epithelium///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from ovarian surface epithelial cells///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657522/GSM657522_HOSE2064.CEL.gz///data_row_count: 22283
1
title: Normal HOSE2085///geo_accession: GSM657523///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian surface epithelial cells///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Normal ovarian surface epithelium///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from ovarian surface epithelial cells///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657523/GSM657523_HOSE2085.CEL.gz///data_row_count: 22283
1
title: Normal HOSE2225///geo_accession: GSM657524///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian surface epithelial cells///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Normal ovarian surface epithelium///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from ovarian surface epithelial cells///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657524/GSM657524_HOSE2225.CEL.gz///data_row_count: 22283
1
title: Normal HOSE2226///geo_accession: GSM657525///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian surface epithelial cells///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Normal ovarian surface epithelium///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from ovarian surface epithelial cells///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657525/GSM657525_HOSE2226.CEL.gz///data_row_count: 22283
1
title: Normal HOSE2228///geo_accession: GSM657526///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian surface epithelial cells///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Normal ovarian surface epithelium///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from ovarian surface epithelial cells///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657526/GSM657526_HOSE2228.CEL.gz///data_row_count: 22283
1
title: Normal HOSE2230///geo_accession: GSM657527///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian surface epithelial cells///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Normal ovarian surface epithelium///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from ovarian surface epithelial cells///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657527/GSM657527_HOSE2230.CEL.gz///data_row_count: 22283
1
title: Normal HOSE2234///geo_accession: GSM657528///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian surface epithelial cells///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Normal ovarian surface epithelium///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from ovarian surface epithelial cells///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657528/GSM657528_HOSE2234.CEL.gz///data_row_count: 22283
1
title: Normal HOSE2237///geo_accession: GSM657519///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian surface epithelial cells///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Normal ovarian surface epithelium///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from ovarian surface epithelial cells///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657519/GSM657519_HOSE2237.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO100///geo_accession: GSM657530///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 4.51///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657530/GSM657530_SO100.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO103///geo_accession: GSM657531///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 4.38///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657531/GSM657531_SO103.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO106///geo_accession: GSM657532///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 1.72///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657532/GSM657532_SO106.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO108///geo_accession: GSM657533///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: AWD (alive with disease)///characteristics_ch1.3: survival years: 3.99///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657533/GSM657533_SO108.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO10///geo_accession: GSM657529///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: AWD (alive with disease)///characteristics_ch1.3: survival years: 7.48///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657529/GSM657529_SO10.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO113///geo_accession: GSM657535///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 3.77///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657535/GSM657535_SO113.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO115///geo_accession: GSM657536///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 2.45///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657536/GSM657536_SO115.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO116///geo_accession: GSM657537///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: AWD (alive with disease)///characteristics_ch1.3: survival years: 3.58///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657537/GSM657537_SO116.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO117///geo_accession: GSM657538///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: AWD (alive with disease)///characteristics_ch1.3: survival years: 3.53///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657538/GSM657538_SO117.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO118///geo_accession: GSM657539///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: AWD (alive with disease)///characteristics_ch1.3: survival years: 3.49///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657539/GSM657539_SO118.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO11///geo_accession: GSM657534///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 2.51///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657534/GSM657534_SO11.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO121///geo_accession: GSM657541///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 3.3///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657541/GSM657541_SO121.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO122///geo_accession: GSM657542///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 2.3///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657542/GSM657542_SO122.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO124///geo_accession: GSM657543///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 3.26///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657543/GSM657543_SO124.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO129///geo_accession: GSM657544///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 2.82///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657544/GSM657544_SO129.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO12///geo_accession: GSM657540///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 0.71///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657540/GSM657540_SO12.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO131///geo_accession: GSM657546///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 2.94///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657546/GSM657546_SO131.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO134///geo_accession: GSM657547///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 1.03///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657547/GSM657547_SO134.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO135///geo_accession: GSM657548///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 3.55///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657548/GSM657548_SO135.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO137///geo_accession: GSM657549///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 0.17///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657549/GSM657549_SO137.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO13///geo_accession: GSM657545///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 7.33///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657545/GSM657545_SO13.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO141///geo_accession: GSM657550///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 1.47///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657550/GSM657550_SO141.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO143///geo_accession: GSM657551///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: AWD (alive with disease)///characteristics_ch1.3: survival years: 6.86///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657551/GSM657551_SO143.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO148///geo_accession: GSM657552///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 2.37///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657552/GSM657552_SO148.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO154///geo_accession: GSM657553///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: AWD (alive with disease)///characteristics_ch1.3: survival years: 3.7///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657553/GSM657553_SO154.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO166///geo_accession: GSM657555///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 2.93///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657555/GSM657555_SO166.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO16///geo_accession: GSM657554///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 6.29///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657554/GSM657554_SO16.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO173///geo_accession: GSM657557///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: AWD (alive with disease)///characteristics_ch1.3: survival years: 2.71///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657557/GSM657557_SO173.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO174///geo_accession: GSM657558///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 2.84///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657558/GSM657558_SO174.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO17///geo_accession: GSM657556///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 3.83///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657556/GSM657556_SO17.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO181///geo_accession: GSM657560///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 2.1///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657560/GSM657560_SO181.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO184///geo_accession: GSM657561///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 2.43///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657561/GSM657561_SO184.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO185///geo_accession: GSM657562///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 2.37///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657562/GSM657562_SO185.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO187///geo_accession: GSM657563///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: AWD (alive with disease)///characteristics_ch1.3: survival years: 2.48///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657563/GSM657563_SO187.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO189///geo_accession: GSM657564///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 2.3///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657564/GSM657564_SO189.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO18///geo_accession: GSM657559///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 6.3///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657559/GSM657559_SO18.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO190///geo_accession: GSM657565///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 2.16///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657565/GSM657565_SO190.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO193///geo_accession: GSM657566///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: AWD (alive with disease)///characteristics_ch1.3: survival years: 2.27///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657566/GSM657566_SO193.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO194///geo_accession: GSM657567///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: AWD (alive with disease)///characteristics_ch1.3: survival years: 2.23///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657567/GSM657567_SO194.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO196///geo_accession: GSM657568///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 1.28///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657568/GSM657568_SO196.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO197///geo_accession: GSM657569///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: AWD (alive with disease)///characteristics_ch1.3: survival years: 2.16///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657569/GSM657569_SO197.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO200///geo_accession: GSM657571///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: AWD (alive with disease)///characteristics_ch1.3: survival years: 2.15///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657571/GSM657571_SO200.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO201///geo_accession: GSM657572///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: AWD (alive with disease)///characteristics_ch1.3: survival years: 2.06///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657572/GSM657572_SO201.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO203///geo_accession: GSM657573///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 1.59///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657573/GSM657573_SO203.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO205///geo_accession: GSM657574///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 1.89///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657574/GSM657574_SO205.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO211///geo_accession: GSM657576///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 4.94///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657576/GSM657576_SO211.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO214///geo_accession: GSM657577///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 2.96///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657577/GSM657577_SO214.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO216///geo_accession: GSM657578///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 1.75///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657578/GSM657578_SO216.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO217///geo_accession: GSM657579///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 1.91///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657579/GSM657579_SO217.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO218///geo_accession: GSM657580///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 4.6///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657580/GSM657580_SO218.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO21///geo_accession: GSM657575///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 0.56///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657575/GSM657575_SO21.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO224///geo_accession: GSM657581///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 3.18///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657581/GSM657581_SO224.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO225///geo_accession: GSM657582///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 8.8///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657582/GSM657582_SO225.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO227///geo_accession: GSM657583///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 5.68///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657583/GSM657583_SO227.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO228///geo_accession: GSM657584///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 6.75///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657584/GSM657584_SO228.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO229///geo_accession: GSM657585///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 0.86///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657585/GSM657585_SO229.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO230///geo_accession: GSM657587///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 3.64///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657587/GSM657587_SO230.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO231///geo_accession: GSM657588///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 5.15///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657588/GSM657588_SO231.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO235///geo_accession: GSM657589///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 0.62///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657589/GSM657589_SO235.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO236///geo_accession: GSM657590///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 13.5///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657590/GSM657590_SO236.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO237///geo_accession: GSM657591///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 0.59///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657591/GSM657591_SO237.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO23///geo_accession: GSM657586///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 6.91///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657586/GSM657586_SO23.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO241///geo_accession: GSM657592///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 3.12///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657592/GSM657592_SO241.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO242///geo_accession: GSM657593///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 0.21///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657593/GSM657593_SO242.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO243///geo_accession: GSM657594///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 13.1///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657594/GSM657594_SO243.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO244///geo_accession: GSM657595///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 0.99///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657595/GSM657595_SO244.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO246///geo_accession: GSM657596///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 3.95///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657596/GSM657596_SO246.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO247///geo_accession: GSM657597///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 5.34///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657597/GSM657597_SO247.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO249///geo_accession: GSM657598///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 6.83///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657598/GSM657598_SO249.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO250///geo_accession: GSM657600///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 8.64///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657600/GSM657600_SO250.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO256///geo_accession: GSM657601///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 1.94///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657601/GSM657601_SO256.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO257///geo_accession: GSM657602///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 2.2///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657602/GSM657602_SO257.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO258///geo_accession: GSM657603///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 1.72///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657603/GSM657603_SO258.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO25///geo_accession: GSM657599///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 3.5///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657599/GSM657599_SO25.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO261///geo_accession: GSM657604///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 0.98///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657604/GSM657604_SO261.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO262///geo_accession: GSM657605///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 7.88///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657605/GSM657605_SO262.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO263///geo_accession: GSM657606///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 3.93///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657606/GSM657606_SO263.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO265///geo_accession: GSM657607///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 0.33///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657607/GSM657607_SO265.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO267///geo_accession: GSM657608///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 1.3///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657608/GSM657608_SO267.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO268///geo_accession: GSM657609///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 9.22///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657609/GSM657609_SO268.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO272///geo_accession: GSM657610///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 3.75///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657610/GSM657610_SO272.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO273///geo_accession: GSM657611///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 2.52///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657611/GSM657611_SO273.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO278///geo_accession: GSM657612///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 4.53///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657612/GSM657612_SO278.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO279///geo_accession: GSM657613///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 0.92///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657613/GSM657613_SO279.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO282///geo_accession: GSM657614///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 2.4///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657614/GSM657614_SO282.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO283///geo_accession: GSM657615///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 0.66///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657615/GSM657615_SO283.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO285///geo_accession: GSM657616///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 2.32///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657616/GSM657616_SO285.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO290///geo_accession: GSM657617///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 3.5///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657617/GSM657617_SO290.CEL.gz///data_row_count: 22283
1
title: Ovarian Cancer SO295///geo_accession: GSM657618///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 3.24///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657618/GSM657618_SO295.CEL.gz///data_row_count: 22283
1
(Other)
96
duplicates:
GSE26712.GSE26712_GSM657526
1
GSE26712.GSE26712_GSM657526///GSE26712.GSE26712_GSM657527
1
GSE26712.GSE26712_GSM657527
1
NA's
192
|
Value
An expression set
R Package Documentation
Browse R Packages
We want your feedback!
Note that we can't provide technical support on individual packages. You should contact the package authors for that.
Embedding an R snippet on your website
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.